Preprint / Version 1

Non-pharmaceutical Treatments for Alzheimer’s Disease


  • Pramati Barath Saint Francis High School



alzheimer's disease, treatment


Over the years, the treatments for Alzheimer’s disease (AD) have significantly evolved, introducing possibilities for non-pharmaceutical treatment. Managing factors such as diet, exercise, and sleep paired with cognitive therapies such as reality orientation training, computerized cognitive therapy, and emotional therapies like reminiscence therapy are being studied for their effectiveness in treating Alzheimer’s disease. It has been found that foods such as leafy greens, lean proteins, and foods rich in omega 3’s, vitamin 3, and whole grains can keep the brain healthy. Exercise is being studied for its ability to increase the presence of the FNDC5/irisin protein in the brain, which is able to enhance synaptic connections in the brain and could rescue the memory impairment that is characteristic of AD. Many of these treatments are also being studied for their preventive efficacy, which could revolutionize Alzheimer’s treatment. Getting good amounts of sleep nightly, for example, is linked with good brain health later on in life. Conversely, getting poor sleep during adulthood has often led to some form of dementia later in life. Many current Alzheimer’s treatments act to mitigate symptoms rather than addressing the root cause or reversing previously done damage. Knowing that there is currently no known cure, taking up a preventive method of care for those predisposed to Alzheimer’s disease opens up the possibility of delaying the onset of symptoms. Different physicians and specialists go about treatments in various ways, often to do with their patient’s particular situation and how late they were diagnosed. Overall, this allows discussion into whether pharmaceutical approaches are perhaps not the only viable option and non-traditional approaches should also be studied in more detail to present an effective treatment.


Agüera-Ortiz, L., García-Ramos, R., Grandas Pérez, F. J., López-Álvarez, J., Montes Rodríguez, J. M., Olazarán Rodríguez, F. J., Olivera Pueyo, J., Pelegrin Valero, C., & Porta-Etessam, J. (2021). Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management. Frontiers in psychiatry, 12, 638651.

Ahlskog, J. E., Geda, Y. E., Graff-Radford, N. R., & Petersen, R. C. (2011). Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clinic proceedings, 86(9), 876–884.

Alzheimer's Association. (2021, October). Tau Topic Sheet - Alzheimer's association.

Avila, J., Lucas, J. J., Perez, M., & Hernandez, F. (2004). Role of tau protein in both physiological and pathological conditions. Physiological reviews, 84(2), 361–384.

Barnes, L. L. (2022, March 23). Mind diet intervention and cognitive decline.

​​Basso, J. C., & Suzuki, W. A. (2016). The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review. Brain Plasticity, 2(2), 127-152.

Beshir, S. A., Aadithsoorya, A. M., Parveen, A., Loon Goh, S. S., Hussain, N., & Menon, V. B. (2021). Aducanumab Therapy to Treat Alzheimer's Disease: A Narrative Review. International Journal of Alzheimer's Disease, 2022.

Bryant, E. (2021, May 4). Lack of sleep in middle age may increase dementia risk. National Institutes of Health.

Chaudhry, S. R., & Gossman, W. (2022, April 5). Biochemistry, Endorphin. Statpearls - NCBI bookshelf. National Library of Medicine.

Csukly, G., Sirály, E., Fodor, Z., Horváth, A., Salacz, P., Hidasi, Z., Csibri, É., Rudas, G., & Szabó, Á. (2016). The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI. Frontiers in aging neuroscience, 8, 52.

Dan, Siddhartha & Sharma, Deeksha & Rastogi, Kartikey & Ojha, Himanshu & Pathak, Mallika & Singhal, Rahul & Shaloo. (2021). Therapeutic and Diagnostic Applications of Nanocomposites in the Treatment Alzheimer's Disease Studies. Biointerface Research in Applied Chemistry. 12. 940-960. 10.33263/BRIAC121.940960.

Fernández-Sanz, P., Ruiz-Gabarre, D., & García-Escudero, V. (2019). Modulating Effect of Diet on Alzheimer's Disease. Diseases (Basel, Switzerland), 7(1), 12.

Forbes, D., Thiessen, E. J., Blake, C. M., Forbes, S. C., & Forbes, S. (2013). Exercise programs for people with dementia. The Cochrane database of systematic reviews, (12), CD006489.

Harvard Health. (2021, March 6). Foods linked to better brain power. Harvard Health.

Hill, N. T., Mowszowski, L., Naismith, S. L., Chadwick, V. L., Valenzuela, M., & Lampit, A. (2017). Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis. The American journal of psychiatry, 174(4), 329–340.

Kelley, B. J., & Petersen, R. C. (2007). Alzheimer’s Disease and Mild Cognitive Impairment. Neurologic clinics, 25(3), 577.

Lacosta, A. M., Pascual-Lucas, M., Pesini, P., Casabona, D., Pérez-Grijalba, V., Marcos-Campos, I., Sarasa, L., Canudas, J., Badi, H., Monleón, I., San-José, I., Munuera, J., Rodríguez-Gómez, O., Abdelnour, C., Lafuente, A., Buendía, M., Boada, M., Tárraga, L., Ruiz, A., & Sarasa, M. (2018). Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial. Alzheimer's research & therapy, 10(1), 12.

Lo, J. C., Ong, J. L., Leong, R. L., Gooley, J. J., & Chee, M. W. (2016). Cognitive Performance, Sleepiness, and Mood in Partially Sleep Deprived Adolescents: The Need for Sleep Study. Sleep, 39(3), 687–698.

Lourenco, M.V., Frozza, R.L., de Freitas, G.B. et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med 25, 165–175 (2019).

NIA. (2017, May 16). What happens to the brain in Alzheimer's disease? National Institute on Aging.

NIA. (2019, November 27). What do we know about diet and prevention of Alzheimer's disease? National Institute on Aging.

NIA. (2021, September 9). How is Alzheimer's disease diagnosed? National Institute on Aging.

NIH. (2021, March 29). APOE gene: MedlinePlus genetics. MedlinePlus.

NIH. (2013, July 3). Non-drug interventions for Alzheimer’s disease. NIH.

Novak, P., Schmidt, R., Kontsekova, E., Zilka, N., Kovacech, B., Skrabana, R., Vince-Kazmerova, Z., Katina, S., Fialova, L., Prcina, M., Parrak, V., Dal-Bianco, P., Brunner, M., Staffen, W., Rainer, M., Ondrus, M., Ropele, S., Smisek, M., Sivak, R., Winblad, B., … Novak, M. (2017). Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet. Neurology, 16(2), 123–134.

Peng, J., & Wu, J. (2022). Effects of the FNDC5/Irisin on Elderly Dementia and Cognitive Impairment. Frontiers in aging neuroscience, 14, 863901.

Rosenvall, A., Sääksvuori, L., Finne-Soveri, H., Linnosmaa, I., & Malmivaara, A. (2020). Potential cost savings for selected non-pharmacological treatment strategies for patients with Alzheimer's disease in Finland. Journal of rehabilitation medicine, 52(9), jrm00106.

Rush University Medical Center. (2021). Mind diet intervention to prevent Alzheimer's disease: National Institute on Aging.

Sabbagh, M. N., Perez, A., Holland, T. M., Boustani, M., Peabody, S. R., Yaffe, K., Bruno, M., Paulsen, R., Wahid, N., & Tanzi, R. E. (2022). Primary prevention recommendations to reduce the risk of cognitive decline. Alzheimer's & Dementia, 18(8), 1569-1579.

Sabia, S., Fayosse, A., Dumurgier, J., Paquet, C., Sommerlad, A., Kivimäki, M., Dugravot, A., & Singh-Manoux, A. (2020). Association of sleep duration in middle and old age with incidence of dementia. Nature Communications, 12.

​​Scisciola, L., Fontanella, R. A., Cataldo, V., Paolisso, G., & Barbieri, M. (2021). Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk. Life, 11(2).

Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., Ralvenius, W. T., Akay, L., Lockshin, E., He, L., Milo, B., Graziosi, A., Baru, V., Lewis, C. A., Kellis, M., Sabatini, D. M., Tsai, L. H., & Lindquist, S. (2021). APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Science translational medicine, 13(583), eaaz4564.

St-Onge, P., Mikic, A., & Pietrolungo, C. E. (2016). Effects of Diet on Sleep Quality. Advances in Nutrition, 7(5), 938-949.

Team, B. and S. (2022, November 11). How exercise is good for your brain. Cleveland Clinic.

Teplow, D. B. (2019). Molecular Biology of Neurodegenerative Diseases: Visions for the Future. Academic Press.

Woods, B., O'Philbin, L., Farrell, E. M., Spector, A. E., & Orrell, M. (2018). Reminiscence therapy for dementia. The Cochrane database of systematic reviews, 3(3), CD001120.

Young, M. F., Valaris, S., & Wrann, C. D. (2019). A Role for FNDC5/Irisin in the Beneficial Effects of Exercise on the Brain and in Neurodegenerative Diseases. Progress in cardiovascular diseases, 62(2), 172.